Bonner R, Albajrami O, Hudspeth J, Upadhyay A. Diabetic kidney disease. Prim Care. 2020;47:645–59.
Article
Google Scholar
Satchell S. The role of the glomerular endothelium in albumin handling. Nat Rev Nephrol. 2013;9:717–25.
Article
CAS
Google Scholar
Jourde-Chiche N, Fakhouri F, Dou L, Bellien J, Burtey S, Frimat M, Jarrot PA, Kaplanski G, Le Quintrec M, Pernin V, Rigothier C, Sallee M, Fremeaux-Bacchi V, Guerrot D, Roumenina LT. Endothelium structure and function in kidney health and disease. Nat Rev Nephrol. 2019;15:87–108.
Article
Google Scholar
Ndisang JF. Glomerular endothelium and its impact on glomerular filtration barrier in diabetes: are the gaps still illusive? Curr Med Chem. 2018;25:1525–9.
Article
CAS
Google Scholar
Sward P, Rippe B. Acute and sustained actions of hyperglycaemia on endothelial and glomerular barrier permeability. Acta Physiol (Oxf). 2012;204:294–307.
Article
CAS
Google Scholar
Gil CL, Hooker E, Larrivee B. Diabetic kidney disease, endothelial damage, and podocyte-endothelial crosstalk. Kidney Med. 2021;3:105–15.
Article
Google Scholar
Eftekhari A, Vahed SZ, Kavetskyy T, Rameshrad M, Jafari S, Chodari L, Hosseiniyan SM, Derakhshankhah H, Ahmadian E, Ardalan M. Cell junction proteins: crossing the glomerular filtration barrier in diabetic nephropathy. Int J Biol Macromol. 2020;148:475–82.
Article
CAS
Google Scholar
Axelsson J, Rippe A, Rippe B. Acute hyperglycemia induces rapid, reversible increases in glomerular permeability in nondiabetic rats. Am J Physiol Renal Physiol. 2010;298:F1306-1312.
Article
CAS
Google Scholar
Dou L, Jourde-Chiche N. Endothelial toxicity of high glucose and its by-products in diabetic kidney disease. Toxins (Basel). 2019;11:578.
Article
CAS
Google Scholar
Korakas E, Ikonomidis I, Markakis K, Raptis A, Dimitriadis G, Lambadiari V. The endothelial glycocalyx as a key mediator of albumin handling and the development of diabetic nephropathy. Curr Vasc Pharmacol. 2020;18:619–31.
Article
CAS
Google Scholar
Wang X, Zhao X, Feng T, Jin G, Li Z. Rutin prevents high glucose-induced renal glomerular endothelial hyperpermeability by inhibiting the ROS/Rhoa/ROCK signaling pathway. Planta Med. 2016;82:1252–7.
Article
CAS
Google Scholar
Zhao XY, Wang XF, Li L, Zhang L, Shen DL, Li DH, Jin QS, Zhang JY. Effects of high glucose on human umbilical vein endothelial cell permeability and myosin light chain phosphorylation. Diabetol Metab Syndr. 2015;7:98.
Article
CAS
Google Scholar
Ramnath RD, Satchell SC. Glomerular endothelial cells: assessment of barrier properties in vitro. Methods Mol Biol. 2020;2067:145–51.
Article
CAS
Google Scholar
Kazakova OA, Khapchaev AY, Shirinsky VP. MLCK and ROCK mutualism in endothelial barrier dysfunction. Biochimie. 2020;168:83–91.
Article
CAS
Google Scholar
Pan XW, Wang MJ, Gong SS, Sun MH, Wang Y, Zhang YY, Li F, Yu BY, Kou JP. YiQiFuMai Lyophilized Injection ameliorates tPA-induced hemorrhagic transformation by inhibiting cytoskeletal rearrangement associated with ROCK1 and NF-kappaB signaling pathways. J Ethnopharmacol. 2020;262:113161.
Article
CAS
Google Scholar
Xu C, Wu X, Hack BK, Bao L, Cunningham PN. TNF causes changes in glomerular endothelial permeability and morphology through a Rho and myosin light chain kinase-dependent mechanism. Physiol Rep. 2015;3:e12636.
Article
CAS
Google Scholar
Yin Q, Xia Y, Wang G. Sinomenine alleviates high glucose-induced renal glomerular endothelial hyperpermeability by inhibiting the activation of RhoA/ROCK signaling pathway. Biochem Biophys Res Commun. 2016;477:881–6.
Article
CAS
Google Scholar
Li Q, Zeng Y, Jiang Q, Wu C, Zhou J. Role of mTOR signaling in the regulation of high glucose-induced podocyte injury. Exp Ther Med. 2019;17:2495–502.
PubMed
PubMed Central
CAS
Google Scholar
Sivertsson E, Friederich-Persson M, Oberg CM, Fasching A, Hansell P, Rippe B, Palm F. Inhibition of mammalian target of rapamycin decreases intrarenal oxygen availability and alters glomerular permeability. Am J Physiol Renal Physiol. 2018;314:F864–72.
Article
CAS
Google Scholar
Axelsson J, Rippe A, Rippe B. mTOR inhibition with temsirolimus causes acute increases in glomerular permeability, but inhibits the dynamic permeability actions of puromycin aminonucleoside. Am J Physiol Renal Physiol. 2015;308:F1056-1064.
Article
CAS
Google Scholar
Puelles VG, van der Wolde JW, Wanner N, Scheppach MW, Cullen-McEwen LA, Bork T, Lindenmeyer MT, Gernhold L, Wong MN, Braun F, Cohen CD, Kett MM, Kuppe C, Kramann R, Saritas T, van Roeyen CR, Moeller MJ, Tribolet L, Rebello R, Sun YB, Li J, Muller-Newen G, Hughson MD, Hoy WE, Person F, Wiech T, Ricardo SD, Kerr PG, Denton KM, Furic L, Huber TB, Nikolic-Paterson DJ, Bertram JF. mTOR-mediated podocyte hypertrophy regulates glomerular integrity in mice and humans. JCI Insight. 2019. https://doi.org/10.1172/jci.insight.99271.
Article
PubMed
PubMed Central
Google Scholar
Liu L, Luo Y, Chen L, Shen T, Xu B, Chen W, Zhou H, Han X, Huang S. Rapamycin inhibits cytoskeleton reorganization and cell motility by suppressing RhoA expression and activity. J Biol Chem. 2010;285:38362–73.
Article
CAS
Google Scholar
Wang T, Shimizu Y, Wu X, Kelly GT, Xu X, Wang L, Qian Z, Chen Y, Garcia JGN. Particulate matter disrupts human lung endothelial cell barrier integrity via Rho-dependent pathways. Pulm Circ. 2017;7:617–23.
Article
CAS
Google Scholar
Fu J, Lee K, Chuang PY, Liu Z, He JC. Glomerular endothelial cell injury and cross talk in diabetic kidney disease. Am J Physiol Renal Physiol. 2015;308:F287-297.
Article
CAS
Google Scholar
Peng H, Li Y, Wang C, Zhang J, Chen Y, Chen W, Cao J, Wang Y, Hu Z, Lou T. ROCK1 induces endothelial-to-mesenchymal transition in glomeruli to aggravate albuminuria in diabetic nephropathy. Sci Rep. 2016;6:20304.
Article
CAS
Google Scholar
Wang Y, Zhang H, Pang T, Zuo Z, Ren K. Rapamycin improves renal injury induced by Iodixanol in diabetic rats by deactivating the mTOR/p70S6K signaling pathway. Life Sci. 2020;259:118284.
Article
CAS
Google Scholar
Zhu L, Wang W, Xie TH, Zou J, Nie X, Wang X, Zhang MY, Wang ZY, Gu S, Zhuang M, Tan J, Shen C, Dai Y, Yang X, Yao Y, Wei TT. TGR5 receptor activation attenuates diabetic retinopathy through suppression of RhoA/ROCK signaling. FASEB J. 2020;34:4189–203.
Article
CAS
Google Scholar